scholarly journals Endovascular Thrombectomy Treatment

2021 ◽  
Vol 30 (4) ◽  
pp. 173-180
Author(s):  
Jayson Lavie ◽  
Ananth K. Vellimana ◽  
Arindam Rano Chatterjee
2021 ◽  
Vol 77 (18) ◽  
pp. 2799
Author(s):  
April Graham ◽  
Jelani Grant ◽  
Dana Gross ◽  
Efren Buitrago ◽  
Alfredo Rego ◽  
...  

2021 ◽  
Vol 9 (5) ◽  
Author(s):  
Kiyoshi Takemoto ◽  
Masaaki Sakuraya ◽  
Michitaka Nakamura ◽  
Hidetsugu Maekawa ◽  
Kazuo Yamanaka ◽  
...  

2021 ◽  
pp. neurintsurg-2020-017205
Author(s):  
Alexandra L Czap ◽  
Alicia M Zha ◽  
Jacob Sebaugh ◽  
Ameer E Hassan ◽  
Julie G Shulman ◽  
...  

BackgroundUnprecedented workflow shifts during the coronavirus disease 2019 (COVID-19) pandemic have contributed to delays in acute care delivery, but whether it adversely affected endovascular thrombectomy metrics in acute large vessel occlusion (LVO) is unknown.MethodsWe performed a retrospective review of observational data from 14 comprehensive stroke centers in nine US states with acute LVO. EVT metrics were compared between March to July 2019 against March to July 2020 (primary analysis), and between state-specific pre-peak and peak COVID-19 months (secondary analysis), with multivariable adjustment.ResultsOf the 1364 patients included in the primary analysis (51% female, median NIHSS 14 [IQR 7–21], and 74% of whom underwent EVT), there was no difference in the primary outcome of door-to-puncture (DTP) time between the 2019 control period and the COVID-19 period (median 71 vs 67 min, P=0.10). After adjustment for variables associated with faster DTP, and clustering by site, there remained a trend toward shorter DTP during the pandemic (βadj=-73.2, 95% CI −153.8–7.4, Pp=0.07). There was no difference in DTP times according to local COVID-19 peaks vs pre-peak months in unadjusted or adjusted multivariable regression (βadj=-3.85, 95% CI −36.9–29.2, P=0.80). In this final multivariable model (secondary analysis), faster DTP times were significantly associated with transfer from an outside institution (βadj=-46.44, 95% CI −62.8 to – -30.0, P<0.01) and higher NIHSS (βadj=-2.15, 95% CI −4.2to – -0.1, P=0.05).ConclusionsIn this multi-center study, there was no delay in EVT among patients treated for intracranial occlusion during the COVID-19 era compared with the pre-COVID era.


2021 ◽  
Vol 2021 (6) ◽  
Author(s):  
Melinda B Roaldsen ◽  
Mirza Jusufovic ◽  
Eivind Berge ◽  
Haakon Lindekleiv

Sign in / Sign up

Export Citation Format

Share Document